Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2013-2824

2. Registrant Information.

Registrant Reference Number: PROSAR Case#: 1-33468558

Registrant Name (Full Legal Name no abbreviations): The Scotts Company LLC

Address: 14111 Scottslawn Road

City: Marysville

Prov / State: Ohio

Country: USA

Postal Code: 43041

3. Select the appropriate subform(s) for the incident.

Human

4. Date registrant was first informed of the incident.

25-APR-13

5. Location of incident.

Country: UNITED STATES

Prov / State: PENNSYLVANIA

6. Date incident was first observed.

24-APR-13

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

---

PMRA Registration No.       PMRA Submission No.       EPA Registration No. 2217-884-73327

Product Name: Vigoro Ultra Turf Phosphorus Free Weed/Feed 28-0-3

• Active Ingredient(s)
  • 2,4-D (PRESENT AS LOW VOLATILE ESTERS)
    • Guarantee/concentration 1.108 %
  • DICAMBA (PRESENT AS ACID, AMINE SALT, ESTER, OR SODIUM SALT)
    • Guarantee/concentration .071 %
  • MECOPROP P-ISOMER (PRESENT AS ACID)
    • Guarantee/concentration .167 %

---

7. b) Type of formulation.

Granular

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Res. - Out Home / Rés - à l'ext.maison

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

No

Subform II: Human Incident Report (A separate form for each person affected)

1. Source of Report.

Other

2. Demographic information of data subject

Sex: Male

Age: >1 <=6 yrs / > 1 < = 6 ans

3. List all symptoms, using the selections below.

System

• Respiratory System
  • Symptom - Respiratory failure

• Nervous and Muscular Systems
  • Symptom - Stiffness
  • Specify - Became stiff
  • Symptom - Unresponsive
  • Specify - went lifeless

• Respiratory System
  • Symptom - Other
  • Specify - not breathing

4. How long did the symptoms last?

<=30 min / <=30 min

5. Was medical treatment provided? Provide details in question 13.

Yes

6. a) Was the person hospitalized?

Unknown

6. b) For how long?

7. Exposure scenario

Non-occupational

8. How did exposure occur? (Select all that apply)

Contact with treated area

Amount of time between application and contact 1

Day(s) / Jour(s)

What was the activity? Ran across the application site with no shoes on

9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)

Unknown

10. Route(s) of exposure.

Skin

11. What was the length of exposure?

Unknown / Inconnu

12. Time between exposure and onset of symptoms.

>30 min <=2 hrs / >30 min <=2 h

13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)

1-33468558 - The reporter, the patients grandmother, indicated that her grandson was exposed to an herbicide containing the active ingredients 2,4-D, Mecoprop-p and Dicamba. The reporter states that the product was applied to her lawn one day prior to initial contact with the registrant. After application the product was not watered in as directed on package label. The following day the reporters (age) year old grandson ran across the lawn with bare feet. Two hours after exposure the reporters grandson was chewing on a lotion container he dropped the container and he started to cry. The lotion container was handed back to the child and he started to chew on it again and within one minute he became lifeless and stiff and was not breathing. The reporter checked the childs airway for an obstruction but saw nothing so she slapped the child on the back. The child came to after he was slapped but he was still dazed. At the time of the initial call the child was still at the ER. The reporter indicated that they will be performing a CT scan and monitoring the child at the ER. The reporter was advised that the product is not absorbed through the skin and after dermal contact transient dermal irritation is possible but the described symptoms are not consistent with the described exposure. The reporter was encouraged to continue working with the childs MD to determine a source for the patients symptoms and appropriate treatment. No further information is available.

To be determined by Registrant

14. Severity classification.

Major

15. Provide supplemental information here.